SUN PHARMACEUTICAL INDUSTRIES, INC.

Lobbying client · New Jersey · filed 2026 to 2026

Pharmaceuticals

$0 Reported spend

1 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 1 filing. Everything on this page is grouped by the client's LDA id (73865), not by name.

Firms hired 1

SUN PHARMACEUTICAL INDUSTRIES, INC. $0 1 filing

Reported by year 1 year

2026 $0 1 filing

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Recent filings 1 total

RR

SUN PHARMACEUTICAL INDUSTRIES, INC.

3rd Quarter (July 1 - Sep 30) 2026 · posted Jul 7, 2026

View →

Foreign entities disclosed 4

SHANGHVI FINANCE PRIVATE LIMITED India named on 1 filing · highest disclosed ownership 40.30% · largest disclosed contribution $0
SUN PHARMACEUTICAL INDUSTRIES LIMITED India named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0
SUN PHARMA HOLDINGS UK LTD. United Kingdom named on 1 filing · highest disclosed ownership 96.35% · largest disclosed contribution $0
SUN PHARMA (NETHERLANDS) B.V. Netherlands named on 1 filing · highest disclosed ownership 96.35% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.